Skip to main content
Premium Trial:

Request an Annual Quote

Two Ways of Doing Things

Premium

The charity Cancer Research UK recently announced that it is partnering with the UK's Department of Health to genetically test the tumors of 9,000 newly diagnosed patients. The idea being, in part, to test different drugs on different cancers and find the best treatments for each. Though the undertaking is still in the early stages, Jimmy Daruwala at the PredictER News blog asks whether personalizing cancer treatment on a national scale is even possible. He says he's concerned about the privacy of patients' health data. The American Cancer Society, though, is planning a study which will follow 300,000 people with no personal history of cancer in order to understand how environmental factors and lifestyle work with genetics to cause cancer or protect people from cancer. "Unlike the UK study, the ACS study seeks to prevent cancer rather than treat it," Durawala says. "The study will collect blood samples, waist measurements, and surveys from study participants. Research subjects derive no direct benefits from the study compared to the UK study; however, ethically speaking the study's website cites specific measures indicated to ensure privacy."

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.